Taverne B., Laborde-Balen G., Sow K., Ndiaye N. B., et Diop K., Treatment success or failure in children and adolescents born with HIV in rural Senegal: An anthropological perspective, Soc Sci Med, vol. 317, p. 115628, janv. 2023. doi: 10.1016/j.socscimed.2022.115628.
Allavena C., Blain H., Abulizi X., Slama L., Katlama C., Delobel P., Rio V., Cagnot C., Raho-Moussa M., Makinson A., et Meyer L., Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older, AIDS, vol. 37, no 1, p. 183‑189, janv. 2023. doi: 10.1097/QAD.0000000000003403.
Joly M., Conte C., Cazanave C., Le Moing V., Tattevin P., Delobel P., Sommet A., et Martin-Blondel G., Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions, Brain, vol. 146, no 1, p. 349‑358, janv. 2023. doi: 10.1093/brain/awac237.
Pouget C., Chatre C., Lavigne J.-P., Pantel A., Reynes J., et Dunyach-Remy C., Effect of Antibiotic Exposure on Staphylococcus epidermidis Responsible for Catheter-Related Bacteremia, Int J Mol Sci, vol. 24, no 2, p. 1547, janv. 2023. doi: 10.3390/ijms24021547.
Overton E. T., Richmond G., Rizzardini G., Thalme A., Girard P.-M., Wong A., Porteiro N., Swindells S., Reynes J., Noe S., Harrington C., Español C. M., Acuipil C., Aksar A., Wang Y., Ford S. L., Crauwels H., van Eygen V., Van Solingen-Ristea R., Latham C. L., Thiagarajah S., D’Amico R., Smith K. Y., Vandermeulen K., et Spreen W. R., Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection: 152-week results from ATLAS-2M, a randomized, open-label, Phase 3b, noninferiority study, Clin Infect Dis, p. ciad020, janv. 2023. doi: 10.1093/cid/ciad020.
Campillo J. T., Hemilembolo M. C., Louya F., Bikita P., Pion S. D. S., Boussinesq M., Missamou F., et Chesnais C. B., Temporal variability of Loa loa microfilaraemia, Parasit Vectors, vol. 16, no 1, p. 23, janv. 2023. doi: 10.1186/s13071-022-05612-0.
Meta Djomsi D., Lacroix A., Soumah A. K., Kinganda Lusamaki E., Mesdour A., Raulino R., Esteban A., Ndong Bass I., Mba Djonzo F. A., Goumou S., Ndimbo-Kimugu S. P., Lempu G., Mbala Kingebeni P., Bamuleka D. M., Likofata J., Muyembe Tamfum J.-J., Toure A., Mpoudi Ngole E., Kouanfack C., Delaporte E., Keita A. K., Ahuka-Mundeke S., Ayouba A., et Peeters M., Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses, Viruses, vol. 15, no 2, p. 337, janv. 2023. doi: 10.3390/v15020337.
Berger M., Daubin D., Charriot J., Klouche K., Le Moing V., Morquin D., Halimi L., Jaussent A., Taourel P., Hayot M., Cristol J.-P., Nagot N., Fesler P., et Roubille C., Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study, J Clin Med, vol. 12, no 3, p. 1000, janv. 2023. doi: 10.3390/jcm12031000.
Boullé C., Chesnais C. B., Kamgno J., Gardon J., Chippaux J.-P., Ranque S., Garcia A., Pion S. D., et Boussinesq M., Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis, Lancet Microbe, vol. 4, no 2, p. e93‑e101, févr. 2023. doi: 10.1016/S2666-5247(22)00331-7.
Frost I., Sati H., Garcia-Vello P., Hasso-Agopsowicz M., Lienhardt C., Gigante V., et Beyer P., The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline, Lancet Microbe, vol. 4, no 2, p. e113‑e125, févr. 2023. doi: 10.1016/S2666-5247(22)00303-2.
Meta Djomsi D., Lacroix A., Soumah A. K., Kinganda Lusamaki E., Mesdour A., Raulino R., Esteban A., Ndong Bass I., Mba Djonzo F. A., Goumou S., Ndimbo-Kimugu S. P., Lempu G., Mbala Kingebeni P., Bamuleka D. M., Likofata J., Muyembe Tamfum J.-J., Toure A., Mpoudi Ngole E., Kouanfack C., Delaporte E., Keita A. K., Ahuka-Mundeke S., Ayouba A., et Peeters M., Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses, Viruses, vol. 15, no 2, p. 337, févr. 2023. doi: 10.3390/v15020337.
Perez L., Corne P., Pasquier G., Konecki C., Sadek M., Le Bihan C., Klouche K., Mathieu O., Reynes J., et Cazaubon Y., Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses, J Fungi (Basel), vol. 9, no 2, p. 211, févr. 2023. doi: 10.3390/jof9020211.
Wroblewski E. E., Guethlein L. A., Anderson A. G., Liu W., Li Y., Heisel S. E., Connell A. J., Ndjango J.-B. N., Bertolani P., Hart J. A., Hart T. B., Sanz C. M., Morgan D. B., Peeters M., Sharp P. M., Hahn B. H., et Parham P., Malaria-driven adaptation of MHC class I in wild bonobo populations, Nat Commun, vol. 14, no 1, p. 1033, févr. 2023. doi: 10.1038/s41467-023-36623-9.
Domínguez J., Boeree M. J., Cambau E., Chesov D., Conradie F., Cox V., Dheda K., Dudnyk A., Farhat M. R., Gagneux S., Grobusch M. P., Gröschel M. I., Guglielmetti L., Kontsevaya I., Lange B., van Leth F., Lienhardt C., Mandalakas A. M., Maurer F. P., Merker M., Miotto P., Molina-Moya B., Morel F., Niemann S., Veziris N., Whitelaw A., Horsburgh C. R., Lange C., et TBnet and RESIST-TB networks, Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement, Lancet Infect Dis, p. S1473-3099(22)00875‑1, févr. 2023. doi: 10.1016/S1473-3099(22)00875-1.
Marcy O., Wobudeya E., Font H., Vessière A., Chabala C., Khosa C., Taguebue J.-V., Moh R., Mwanga-Amumpaire J., Lounnas M., Mulenga V., Mavale S., Chilundo J., Rego D., Nduna B., Shankalala P., Chirwa U., De Lauzanne A., Dim B., Tiogouo Ngouana E., Folquet Amorrissani M., Cisse L., Amon Tanoh Dick F., Komena E. A., Kwedi Nolna S., Businge G., Natukunda N., Cumbe S., Mbekeka P., Kim A., Kheang C., Pol S., Maleche-Obimbo E., Seddon J. A., Mao T. E., Graham S. M., Delacourt C., Borand L., Bonnet M., et TB-Speed Pneumonia Study Group, Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial, Lancet Infect Dis, vol. 23, no 3, p. 341‑351, mars 2023. doi: 10.1016/S1473-3099(22)00668-5.
Mondesert E., Reynes J., Makinson A., Bargnoux A.-S., Plawecki M., Morquin D., Cristol J.-P., et Badiou S., Cystatin C in addition to creatinine for better assessment of glomerular renal function decline in people with HIV receiving antiretroviral therapy, AIDS, vol. 37, no 3, p. 447‑454, mars 2023. doi: 10.1097/QAD.0000000000003434.
Bachelard A., Isernia V., Charpentier C., Benalycherif A., Mora M., Donadille C., Duvivier C., Lacombe K., El Mouhebb M., Spire B., Landman R., Descamps D., Peytavin G., Assoumou L., Ghosn J., et FAST study group, Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055, J Antimicrob Chemother, vol. 78, no 3, p. 769‑778, mars 2023. doi: 10.1093/jac/dkad008.